Related Experiment Video

Updated: Aug 10, 2026

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis

J N Whitaker

    Neurology
    |October 1, 1977
    PubMed

    Insights

    Elevated levels of myelin encephalitogenic protein-P1 fragment in cerebrospinal fluid indicate active multiple sclerosis exacerbations. This biomarker is primarily detected during acute phases, distinguishing it from stable or progressive multiple sclerosis cases.

    Area of Science:

    • Neuroimmunology
    • Neurology
    • Biochemistry

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
    • Identifying reliable biomarkers for acute MS exacerbations is crucial for diagnosis and management.

    Purpose of the Study:

    • To investigate the presence and significance of the P1 fragment of myelin encephalitogenic protein (residues 43-88) in cerebrospinal fluid (CSF) during different phases of multiple sclerosis.

    Main Methods:

    • Double-antibody radioimmunoassay was employed to quantify myelin encephalitogenic protein-P1 levels in unconcentrated CSF.
    • CSF samples were analyzed from patients with acute MS exacerbations, stable MS, and healthy controls.

    Main Results:

    • Myelin encephalitogenic protein-P1 was detected in 8 of 14 patients during the acute phase of MS (3.4-15.4 ng/mL).
    • The protein was present in 6 of 7 individuals within the first week of an exacerbation but absent in stable or progressive MS patients.
    • Detectable levels were found in 6 of 117 controls, with only two showing levels comparable to acute MS patients.

    Conclusions:

    • The presence of myelin encephalitogenic protein-P1 in CSF is characteristic of acute multiple sclerosis exacerbations.
    • While not entirely specific, this biomarker shows potential for identifying active inflammatory phases in MS.

    More Related Videos

    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis09:01

    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

    Published on: November 17, 2020

    Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis08:17

    Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

    Published on: February 23, 2024

    Related Concept Videos

    Encephalitis l: Introduction01:19

    Encephalitis l: Introduction

    Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
    Encephalitis ll: Pathophysiology01:26

    Encephalitis ll: Pathophysiology

    Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...